AzTrials
AzTrials

Uterine AnteflexionFLEXIMIXNCT06669845

Prospective Study of the Variation in the Angle of Anteflexion of the Uterus Before and After Micturition in Nulliparous Women With Uterine Anteversion.

A study testing Ultrasonography, Pelvic in people with Uterine Anteflexion, run by University Hospital, Brest at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A monocentric, prospective, comparative, and descriptive clinical study examining the uterine anteflexion angle before and after bladder emptying in nulliparous women with uterine anteversion. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Uterine Anteflexion
What is being tested?
Ultrasonography, Pelvic
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteFrance
Study dates
12 Nov 2024to 10 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Women aged 18 and over;
  • Nulliparous ;
  • Feeling the need to urinate;
  • Affiliated to a Social Security scheme.

Who cannot join

  • Pregnant women;
  • Desire of pregnancy with conception in progress;
  • Primary amenorrhea ;
  • Menopause ;
  • Previous surgical termination of pregnancy;
  • Previous medical abortion;
Show all 11Show fewer
  • Previous hysterectomy ;
  • Previous conization;
  • Absence of uterus;
  • Irrepressible need to urinate;
  • Inability or refusal to participate in the study.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Brest

    Brest, 29609

Other trials in France

About this study

A monocentric, prospective, comparative, and descriptive clinical study examining the uterine anteflexion angle before and after bladder emptying in nulliparous women with uterine anteversion. The study aims to assess how bladder fullness affects the anteflexion angle, which may impact the ease of intrauterine device (IUD) insertion. The primary objective is to determine the variation in the angle of anteflexion of the uterus before and after micturition in nulliparous women with uterine anteversion. Ultrasound measurements will be taken before and after bladder emptying. A secondary objective is to determine the prevalence of uterine anteversion in nulliparous women.

Being tested
Ultrasonography, Pelvic
Keywords
Uterine anteflexion, Nulliparous women, Full bladder, Ultrasound measurements

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasonography, PelvicProcedure or surgery

    Ultrasound measurements will be taken before and after bladder emptying. The axes of the uterine body, cervix and vagina will be marked out by tracing the 3 corresponding lines on the image.

Study groups in NCT06669845
Study groupRoleWhat they receive
Ultrasonography pelvicOtherUltrasound measurements before and after bladder emptying
Receives: Procedure: Ultrasonography, Pelvic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To determine the variation in the angle of anteflexion of the uterus before and after micturition in nulliparous women with uterine anteversion.

    Difference between mean uterine anteflexion angle full bladder and empty bladder in nulliparous women with uterine anteversion.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2024
  2. Study start12 Nov 2024
  3. Primary completion10 Dec 2024
  4. Study completion10 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06669845
Sponsor's protocol ID
29BRC24.0124
Other IDs
2024-A01255-42
Acronym
FLEXIMIX
Status last verified
Feb 2025
First submitted
31 Oct 2024
Last updated
28 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasonography, Pelvic in people with Uterine Anteflexion, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To determine the variation in the angle of anteflexion of the uterus before and after micturition in nulliparous women with uterine anteversion. (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in